학술논문
Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
Document Type
Article
Author
Source
In: Anticancer Research . (Anticancer Research, April 2024, 44(4):1499-1504)
Subject
Language
English
ISSN
17917530
02507005
02507005